Intelligent Bio Solutions to Participate in Noble Capital Markets’ 21st Annual Emerging Growth Equity Conference on December 2-3, 2025
Rhea-AI Summary
Intelligent Bio Solutions (NASDAQ: INBS) announced management will participate in Noble Capital Markets’ 21st Annual Emerging Growth Equity Conference on December 2–3, 2025 in Boca Raton, Florida.
The company will present on Wednesday, December 3, 2025 at 11:00 a.m. ET in Presentation Room 2 at Florida Atlantic University. A webcast recording will be available the following day on the company investor relations site, Noble’s website, and Channelchek for 90 days.
Investors may register with discount code INBSNOBLECON. To schedule one-on-one meetings or request more information, contact a Noble Capital Markets representative or email KCSA Strategic Communications at INBS@ksca.com.
Positive
- None.
Negative
- None.
News Market Reaction
On the day this news was published, INBS declined 6.30%, reflecting a notable negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
NEW YORK, Nov. 20, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced that its management team will participate in Noble Capital Markets’ 21st Annual Emerging Growth Equity Conference, taking place over December 2-3, 2025, in Boca Raton, Florida.
Conference Details
Date: December 2–3, 2025
Location: Florida Atlantic University, Boca Raton, FL
Presentation Date and Time: Wednesday, December 3, 2025, 11:00 a.m. Eastern Time
Presentation Location: Presentation Room 2
A webcast recording of INBS’s presentation will be available the following day on INBS’s investor relations website, as well as Noble’s website and on Channelchek, for 90 days after the event.
Interested investors can register to attend here using the discount code INBSNOBLECON.
For more information about the conference, or to schedule a one-on-one meeting with the INBS management team, please contact your Noble Capital Markets representative or email KCSA Strategic Communications at INBS@ksca.com.
About Intelligent Bio Solutions Inc.
Intelligent Bio Solutions Inc. (NASDAQ: INBS) is a medical technology company delivering intelligent, rapid, non-invasive testing solutions. The Company believes that its Intelligent Fingerprinting Drug Screening System will revolutionize portable testing through fingerprint sweat analysis, which has the potential for broader applications in additional fields. Designed as a hygienic and cost-effective system, the test screens for the recent use of drugs commonly found in the workplace, including opiates, cocaine, methamphetamine, and cannabis. With sample collection in seconds and results in under ten minutes, this technology would be a valuable tool for employers in safety-critical industries. The Company’s current customer segments outside the U.S. include construction, manufacturing and engineering, transport and logistics firms, mining, drug treatment organizations, and coroners.
For more information, visit https://ibs.inc/
Company Contact
Intelligent Bio Solutions Inc.
info@ibs.inc
LinkedIn | Twitter
Investor & Media Contact
Valter Pinto, Managing Director
KCSA Strategic Communications
PH: (212) 896-1254
INBS@kcsa.com
FAQ
When will Intelligent Bio Solutions (INBS) present at the Noble Capital Markets conference?
How can investors watch the INBS presentation webcast and for how long will it be available?
How do I register to attend the Noble Capital Markets conference for INBS presentations?
Where is Noble Capital Markets’ 21st Annual Emerging Growth Equity Conference held on December 2–3, 2025?
How can investors schedule a one-on-one meeting with INBS management at the conference?
